<html>
<head>
<META http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>NCT00826579 on 2009_01_21: ClinicalTrials.gov Archive</title>
<link rel="stylesheet" href="/archive/history.css">
<link rel="stylesheet" href="/archive/received.css">
</head>
<body class="received">
<div class="navTop"><table class="navTopTriptych"><tr><td class="navTopTriptychL"><img src="/archive/ctgov_logo_ttl.gif" alt="ClinicalTrials.gov" width="360" height="47" /></td><td class="navTopTriptychC" style="background-image: url(/archive/ctgov_logo_ttm.gif)" /><td class="navTopTriptychR"><img src="/archive/ctgov_logo_ttr.gif" alt="Linking patients to medical research" width="314" height="47" /></td></tr></table></div>
<div id="navLinks" class="navLinks"><a href="/archive/NCT00826579">&#8592; History of this study</a><a href="http://clinicaltrials.gov/show/NCT00826579">&#8593; Current version of this study</a></div><h1>View of NCT00826579 on
  2009_01_21</h1>
<table class="info">
<tr>
<th nowrap>ClinicalTrials Identifier:</th><td>NCT00826579</td>
</tr>
<tr>
<th>Updated:</th><td>2009_01_21</td>
</tr>
<tr>
<th class="section" colspan="2">
<h2>Descriptive Information</h2>
</th>
</tr>
<tr>
<th>Brief title</th><td>
<p>Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer</p>
</td>
</tr>
<tr>
<th>Official title</th><td>
<p>Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer</p>
</td>
</tr>
<tr>
<th>Brief summary</th>
</tr>
<tr>
<td colspan="2" class="bigdent">
<p>The study is a feasibility and validation study of the sentinel lymph node (SLN) procedure in all stages of colon cancer. If the SLN can be reliably identified, it could be submitted to a more accurate histopathological examination (multiple sections, special staining). The detection of micrometastases in the SLN (occult stage III, upstaging) is possible. Patients with micrometastases should be considered at higher risk.<br>Additionally, a search for occult metastatic tumor cells in the bone marrow is performed.</p>
</td>
</tr>
<tr>
<th>Detailed description</th>
</tr>
<tr>
<td colspan="2" class="bigdent">
<p></p>
</td>
</tr>
<tr>
<th>Phase</th><td> Phase 1 </td>
</tr>
<tr>
<th>Phase</th><td> Phase 2 </td>
</tr>
<tr>
<th>Study type</th><td>Interventional</td>
</tr>
<tr>
<th>Study design</th><td>Diagnostic</td>
</tr>
<tr>
<th>Study design</th><td>Non-Randomized</td>
</tr>
<tr>
<th>Study design</th><td>Open Label</td>
</tr>
<tr>
<th>Study design</th><td>Uncontrolled</td>
</tr>
<tr>
<th>Study design</th><td>Single Group Assignment</td>
</tr>
<tr>
<th>Study design</th><td>Safety/Efficacy Study</td>
</tr>
<tr>
<th>Primary outcome</th><td>Measure: To assess the extent of upstaging due to the SLN procedure for colon cancer.<br>Time Frame: 1 month<br>Safety Issue? No</td>
</tr>
<tr>
<th>Secondary outcome</th><td>Measure: To evaluate the accuracy of the SLN procedure for colon cancer. To identify factors influencing the success of the procedure. To correlate SLN results with the presence of colon cancer cell in bone marrow aspirates. To assess OS and DFS.<br>Time Frame: 1 month, 3 and 5 years after surgery<br>Safety Issue? No</td>
</tr>
<tr>
<th>Condition</th><td>
         Colonic Neoplasms
      </td>
</tr>
<tr>
<th>Arm/Group</th><td>
<div>Arm Label: Colon cancer      
            &nbsp; &nbsp; &nbsp; &nbsp;
        Experimental</div>
<p>Colon cancer patients of all stages</p>
</td>
</tr>
<tr>
<th>Intervention</th><td>
<div>Procedure/Surgery: Sentinel lymph node procedure
            &nbsp; &nbsp; &nbsp; &nbsp;
            Arm Label: Colon cancer</div>
<p>After careful mobilization of the affected colon segment, isosulfan blue 1% is injected in vivo into the subserosa circumferentially around the tumor. Lymph nodes in the mesentery staining blue within the first minutes are marked as SLN. The procedure is followed by a resection of the affected colon segment with standard lymphadenectomy.</p>
</td>
</tr>
<tr>
<th>Intervention</th><td>
<div>Procedure/Surgery: Bone marrow aspiration
            &nbsp; &nbsp; &nbsp; &nbsp;
            Arm Label: Colon cancer</div>
<p>Prior to surgery, bone marrow is aspirated from both iliac crests. Bone marrow aspirates are analyzed for the presence of occult metastatic colon cancer cells.</p>
</td>
</tr>
<tr>
<th class="section" colspan="2">
<h2>Recruitment Information</h2>
</th>
</tr>
<tr>
<th>Status</th><td>Active, not recruiting</td>
</tr>
<tr>
<th>Start date</th><td>
         2000-05
      </td>
</tr>
<tr>
<th>Last follow-up date</th><td>
         2011-12
      
      (Anticipated)
  </td>
</tr>
<tr>
<th>Primary completion date</th><td>
         2009-01
      
      (Actual)
  </td>
</tr>
<tr>
<th>Criteria</th>
</tr>
<tr>
<td colspan="2" class="bigdent">
<p>Inclusion Criteria:<br>- Colon cancer at any stage diagnosed histologically or high degree of suspicion for colon cancer at endoscopy, which cannot be confirmed with certainty in the biopsy. The diagnosis of cancer must be certain in the definitive histology.<br>- Possibility of transabdominal injection of the dye (cancers below the peritoneal reflection in which the injection of dye must be carried out through rectoscopy, are therefore excluded).<br>- Patient's informed consent<br>
<br>Exclusion Criteria:<br>- Prior intrabdominal tumor surgery<br>- Other preexisting malignancies<br>- Hypersensitivity/allergy to dye (isosulfan blue)<br>- Pregnancy<br>- Breast-feeding<br>- No patient's informed consent</p>
</td>
</tr>
<tr>
<th>Gender</th><td>
            Both
         </td>
</tr>
<tr>
<th>Healthy volunteers</th><td>No</td>
</tr>
<tr>
<th class="section" colspan="2">
<h2>Administrative Data</h2>
</th>
</tr>
<tr>
<th>Organization name</th><td>University Hospital, Basel, Switzerland</td>
</tr>
<tr>
<th>Organization study ID</th><td>Rhein4031</td>
</tr>
<tr>
<th>Sponsor</th><td>
               University Hospital, Basel, Switzerland
            </td>
</tr>
<tr>
<th>Health Authority</th><td>
               Switzerland: Ethikkommission
         </td>
</tr>
</table><div class="navBottom"><div class="navBottomLine" style="background-image: url(/archive/ctgov_logo_ttm.gif)">&#160;</div><div class="navBottomLinks">&#160;</div></div></body>
</html>
